PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of additional years of healthy life globally. Some examples of disease areas in which ...

The UK's National Health Service (NHS) has launched the world's largest prospective trial of using artificial intelligence (AI) to assess routine mammogram screenings. Nearly 700 000 women who have ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...

Randomized controlled trials are clinical trials in which at least two interventions — the test treatment and a control treatment — are simultaneously evaluated in two or more arms of the ...

Using notes from journalists and his observations during the Frankfurt Auschwitz Trials of 1963–1965, Weiss condensed the original judicial statements into a total of 11 chapters, to depict the ...

LibreClinica is the community driven successor of OpenClinica. It is an open source clinical trial software for Electronic Data Capture (EDC) Clinical Data Management (CDM).

This study was a multicentre, double blind, randomised, placebo controlled clinical trial conducted in 16 centres in China. Eligible participants were aged 20 to 70 years, had a body mass index ...

("Revance" together with Dermata "Companies") today announced the Companies have entered into a clinical trial collaboration agreement to evaluate the topical application of Xyngari™ (formerly ...